Risk factors, management, and future fertility of empty follicle syndrome: a retrospective study with real-world data

被引:0
|
作者
Luo, Zhuoye [1 ,2 ,3 ,4 ]
Xu, Suxin [1 ,2 ,3 ,4 ]
Hao, Guimin [1 ,2 ,3 ,4 ]
机构
[1] Hebei Med Univ, Dept Reprod Med, Hosp 2, Shijiazhuang, Peoples R China
[2] Hebei Ctr Qual Control & Management Human Assisted, Shijiazhuang, Peoples R China
[3] Hebei Key Lab Infertil & Hered, Shijiazhuang, Peoples R China
[4] Hebei Clin Res Ctr Birth Defects, Shijiazhuang, Peoples R China
来源
关键词
empty follicle syndrome; oocyte trigger; hCG exposure time; polycystic ovary syndrome; cumulative live birth rate; IN-VIVO; MATURATION; HCG; INTERVAL; PREVALENCE; GENE;
D O I
10.3389/fendo.2024.1424837
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Empty follicle syndrome (EFS) is a challenging clinical problem. This study aims to identify the risk factors for EFS, to present pregnancy outcomes in both EFS cycle as well as subsequent cycles, and to summarize an effective rescue protocol to improve outcomes. Methods: A retrospective analysis between 2016 and 2020 was conducted at our center. Stricter criteria were applied to diagnose EFS. Logistic regression analysis was used to identify the risk factors for EFS. Further analyses were performed within the EFS cycle to present pregnancy outcomes and to find optimal rescue protocols. Long-term follow-up was conducted until live birth was achieved, covering at least two complete oocyte retrieval cycles. Results: Among 14,066 patients, 54 (0.38%) were identified as EFS. Patients with polycystic ovary syndrome (PCOS) had a significantly higher risk of developing EFS than non-PCOS ones (aOR = 2.67; 95% CI, 1.47 to 4.83). Within EFS patients, delaying the second oocyte retrieval by 3-6 h significantly improved the rates of obtaining oocyte (97.4% versus 58.3%, P = 0.002), getting embryo available for transfer (92.3% versus 33.3%, P < 0.001), and pregnancy (48.7% versus 8.3%, P = 0.017) compared to other delayed retrieval times. Overall, 31.5% (17/54) and 46.7% (7/15) EFS patients achieved live birth in the EFS cycle and the future cycle, respectively. Conclusions: PCOS is an independent risk factor for EFS, indicating that longer exposure time to human chorionic gonadotropin (hCG) may be necessary. Delaying the second oocyte retrieval by 3-6 h is an effective rescue protocol for EFS patients to achieve optimal outcomes. EFS in a single cycle does not necessarily indicate future fertility decline, but repeated EFS may result in poor outcomes.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Mortality risk factors in primary Sjogren syndrome: a real-world, retrospective, cohort study
    Brito-Zeron, Pilar
    Flores-Chavez, Alejandra
    Horvath, Ildiko Fanny
    Rasmussen, Astrid
    Li, Xiaomei
    Olsson, Peter
    Vissink, Arjan
    Priori, Roberta
    Armagan, Berkan
    Hernandez-Molina, Gabriela
    Praprotnik, Sonja
    Quartuccio, Luca
    Inanc, Nevsun
    Ozkiziltas, Burcugul
    Bartoloni, Elena
    Sebastian, Agata
    Romao, Vasco C.
    Solans, Roser
    Pasoto, Sandra G.
    Rischmueller, Maureen
    Galisteo, Carlos
    Suzuki, Yasunori
    Trevisani, Virginia Fernandes Moca
    Fugmann, Cecilia
    Gonzalez-Garcia, Andres
    Carubbi, Francesco
    Jurcut, Ciprian
    Shimizu, Toshimasa
    Retamozo, Soledad
    Atzeni, Fabiola
    Hofauer, Benedikt
    Melchor-Diaz, Sheila
    Gheita, Tamer
    Lopez-Dupla, Miguel
    Fonseca-Aizpuru, Eva
    Giacomelli, Roberto
    Vazquez, Marcos
    Consani, Sandra
    Akasbi, Miriam
    Nakamura, Hideki
    Szanto, Antonia
    Farris, A. Darise
    Wang, Li
    Mandl, Thomas
    Gattamelata, Angelica
    Kilic, Levent
    Pirkmajer, Katja Perdan
    Abacar, Kerem
    Tufan, Abdurrahman
    de Vita, Salvatore
    ECLINICALMEDICINE, 2023, 61
  • [2] Using machine learning to identify risk factors for pancreatic cancer: a retrospective cohort study of real-world data
    Su, Na
    Tang, Rui
    Zhang, Yice
    Ni, Jiaqi
    Huang, Yimei
    Liu, Chunqi
    Xiao, Yuzhou
    Zhu, Baoting
    Zhao, Yinglan
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [3] REAL-WORLD DATA MANAGEMENT
    VANRENSSELAER, C
    COMPUTER DECISIONS, 1988, 20 (10): : 50 - 53
  • [4] Real-world study: from real-world data to real-world evidence
    Wen, Yi
    TRANSLATIONAL BREAST CANCER RESEARCH, 2020, 1
  • [5] Cenobamate: real-world data from a retrospective multicenter study
    Lauxmann, Stephan
    Heuer, David
    Heckelmann, Jan
    Fischer, Florian P.
    Schreiber, Melanie
    Schriewer, Elisabeth
    Widman, Guido
    Weber, Yvonne
    Lerche, Holger
    Alber, Michael
    Schuh-Hofer, Sigrid
    Wolking, Stefan
    JOURNAL OF NEUROLOGY, 2024, : 6596 - 6604
  • [6] Management of cardiovascular risk in primary prevention: real-world data
    Danchin, N.
    Puymirat, E.
    Vedrenne, G.
    Durand, E.
    ARCHIVES OF CARDIOVASCULAR DISEASES SUPPLEMENTS, 2012, 4 (04) : 279 - 283
  • [7] Identifying new safety risk of human serum albumin: a retrospective study of real-world data
    Lu, Hui
    Zhang, Yuwei
    Liu, Pengcheng
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [8] Management of atherosclerosis risk factors for patients at high cardiovascular risk in real-world practice: a multicentre study
    Phrommintikul, Arintaya
    Krittayaphong, Rungroj
    Wongcharoen, Wanwarang
    Yamwong, Sukit
    Boonyaratavej, Smonporn
    Kunjara-Na-Ayudhya, Rapeephon
    Tatsanavivat, Pyatat
    Sritara, Piyamitr
    SINGAPORE MEDICAL JOURNAL, 2017, 58 (09) : 535 - 542
  • [9] The year in arrythmias: real-world data on risk factors, ablation, and genetics
    Luscher, Thomas F.
    EUROPEAN HEART JOURNAL, 2019, 40 (10) : 791 - 794
  • [10] Real-world data on severe lung cancer: a multicenter retrospective study
    Wang, Fei
    Xie, Xiaohong
    Wang, Liqiang
    Deng, Haiyi
    Wang, Qian
    Qi, Min
    Guo, Min
    Chen, Juan
    Zhou, Maolin
    Sun, Ni
    Li, Ru
    Yang, Yilin
    He, Zuer
    Lin, Xinqing
    Liu, Ming
    Wu, Di
    Sun, Gengyun
    Zhou, Chengzhi
    TRANSLATIONAL LUNG CANCER RESEARCH, 2023, 12 (03) : 460 - +